(Q45351076)

13 December 2017

title

High levels of hepatitis B virus after the onset of disease lead to chronic infection in patients with acute hepatitis B. (English)

1 reference

13 December 2017

1 reference

1 reference

11

Kazuhiko Koike

1 reference

13 December 2017

Hiroshi Yotsuyanagi

1

1 reference

13 December 2017

Kiyoaki Ito

2

1 reference

13 December 2017

Norie Yamada

3

1 reference

13 December 2017

Hideaki Takahashi

4

1 reference

13 December 2017

Chiaki Okuse

5

1 reference

13 December 2017

Kiyomi Yasuda

6

1 reference

13 December 2017

Michihiro Suzuki

7

1 reference

13 December 2017

Kyoji Moriya

8

1 reference

13 December 2017

Masashi Mizokami

9

1 reference

13 December 2017

Yuzo Miyakawa

10

1 reference

13 December 2017

language of work or name

English

0 references

publication date

23 May 2013

1 reference

Clinical Infectious Diseases

13 December 2017

published in

1 reference

13 December 2017

volume

57

1 reference

13 December 2017

issue

7

1 reference

13 December 2017

page(s)

935-942

1 reference

Case-control study for the identification of virological factors associated with fulminant hepatitis B.

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT348

Does hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT348

Hepatitis B virus strains of subgenotype A2 with an identical sequence spreading rapidly from the capital region to all over Japan in patients with acute hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT348

Clinical features of hepatitis B virus genotype A in Japanese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT348

Distinct geographic distributions of hepatitis B virus genotypes in patients with acute infection in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT348

Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT348

Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen-positive chronic hepatitis B using on-treatment hepatitis B surface antigen decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT348

Kinetics of hepatitis B surface antigen decline during 3 years of telbivudine treatment in hepatitis B e antigen-positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT348

Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT348

Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT348

Frequent coinfection with hepatitis B virus strains of distinct genotypes detected by hybridization with type-specific probes immobilized on a solid-phase support.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT348

Distribution of hepatitis B virus genotypes among patients with chronic infection in Japan shifting toward an increase of genotype A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT348

Estimation of average number of nucleotide substitutions when the rate of substitution varies with nucleotide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT348

Clinical features and viral sequences of various genotypes of hepatitis B virus compared among patients with acute hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT348

Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT348

Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT348

Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT348

A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT348

Kinetics of hepatitis B surface antigen differ between treatment with peginterferon and entecavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT348

21 January 2018

Identifiers

DOI

10.1093/CID/CIT348

1 reference

13 December 2017

1 reference